期刊文献+

HLA-DR基因与肝细胞癌的相关性研究 被引量:4

Study on the correlation between HLA-DR alleles and hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨中国HBV感染人群HLA-DR基因与肝细胞癌的相关性。方法应用PCR-SSP方法对102例慢性乙型肝炎患者(实验1组)、38例肝硬化患者(实验2组)、34例肝细胞癌患者(实验3组)及1383例中华骨髓库山东分库无血缘关系自愿骨髓捐献者(对照组)的HLA-DR等位基因进行检测,分析其表达与肝细胞癌的相关性。结果HLA-DR1在实验3组中的分布频率较对照组明显增高(χ2=4.80,P<0.05),HLA-DR13在实验3组中的分布频率较实验1组明显增高(χ2=5.56,P<0.05),实验2组与实验3组比较差异均无统计学意义。结论HLA-DR1可能是肝细胞癌的易感基因,携带HLA-DR13基因位点的HBV感染者更易发展为肝细胞癌,HLA-DR各等位基因表型频率在肝硬化和肝细胞癌患者中的分布无差异。 Objective To investigate the association between HLA-DR alleles and hepatocellular carcinoma. Methods Experiment groups were composed of 102 patients with chronic hepatitis B (groupl), 38 patients with liver cirrhosis (group2) and 34 patients with hepatocellular carcinoma ( group3 ). The control group was composed of 1383 marrow donors from China Marrow Bank Shandong Branch. HLA-DR were typed by PCR- SSP. Results HLA-DR1 were significantly more frequent in group3 compared with the control group (X^2 = 4. 80, P 〈 0.05 ), HLA-DR 13 was significantly more frequent in group 3 compared with groupl (X^2 = 5.56, P 〈 0. 05 ), there was no significant difference between group 2 and group 3. Conclusion The HLA-DR 1 might be associated with hepatocellular carcinoma. Patients with HBV infection,who carried HLA-DR13 allelie genes had hepatoeellular carcinoma easier. All kinds of HLA-DR allelic genes had no significantly different frequency between patients with liver cirrhosis and those with hepatocellular carcinoma.
出处 《中国实用医药》 2008年第30期27-28,共2页 China Practical Medicine
关键词 HLA-DR 肝细胞癌 肝硬化 慢性乙型肝炎 HLA-DR Hepatocellular carcinoma Liver cirrhosis Chronic hepatitis B
  • 相关文献

参考文献4

二级参考文献22

共引文献1972

同被引文献68

  • 1袁俊华,崔萌,孙成刚,于会莉.HLA-DRB~*1201/~*1501与HBV感染不同状态的相关性[J].山东大学学报(医学版),2005,43(5):428-431. 被引量:9
  • 2黄海玲,解继胜,黄赞松,赵琼芝.TNF-α-238G/A基因多态性与原发性肝癌的关系[J].解剖科学进展,2007,13(1):11-13. 被引量:7
  • 3钱斌,戴晓汶,黄晓峰,王金泉,张宝燕,孙国英,周一平.E-CD、EGFR及HLA-DR在肝细胞癌中的表达及意义[J].东南国防医药,2007,9(2):137-139. 被引量:1
  • 4陈兰羽,陈建杰,章晓鹰.上海地区汉族人群肝细胞癌与HLA-DRB1*17等位基因遗传易感性相关的研究[J].浙江医学,2007,29(4):305-306. 被引量:6
  • 5BUNEE MO, NEIL CM, BARNARD MC, et al. Phototyping comprehensive DNA typing for HLA-A,B,C,DRB1,DRB3,DRB4, DRB5& DOB1 by PCR with 144 primer mixes utilizing sequence specific Primers (PCR-SSP)[J]. Tissue Antigens, 1995, 46(5): 355-367.
  • 6BROWNING M, PETRONZELLI F, BIEKNELL D, et al. Mechanisms of loss of HLA class I expression on colorectal tumor cells[J]. Tissue-Antigens, 1996, 47(5): 364-371.
  • 7KEW MC, GEAR A J, BAUMGARTEN I, et al. Histocompatibility antigen in patients with hepatoeel lular carcinoma and their relationship to chronic hepatitis B virus infection in thesepatients[J]. Gastroenterology, 1979, 77(3): 537-539.
  • 8LOPEZ-VAZQUEZ A, RODRIGO L, MINA-BLANCO A, et al, Extended human leukocyte antigen haplotype EHI8.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection[J]. J Infect Dis, 2004, 189(6): 957-963.
  • 9EI-CHENNAWI FA, AUF FA, METWALLY SS, et al. ss 11 alleles in Egyptian patients with hepatocenular carcinoma [J]. Immunol Invest. 2008, 37(7): 661-674.
  • 10QI L, OSTRAND-ROSENBERG S. MHC class II presentation of endogenous tumor antigenby cellular vaccines depends on the endocytic pathway but not H2-M [J]. Tragic, 2000, 1 (2): 152-160.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部